Connor, Clark & Lunn Investment Management Ltd. - ATARA BIOTHERAPEUTICS INC ownership

ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 125 filers reported holding ATARA BIOTHERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of ATARA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2022$149,000
-81.8%
39,307
-62.5%
0.00%
-80.0%
Q2 2022$817,000
+91.8%
104,898
+128.8%
0.01%
+150.0%
Q1 2022$426,000
+46.4%
45,847
+148.1%
0.00%
+100.0%
Q4 2021$291,000
+1.7%
18,477
+15.7%
0.00%0.0%
Q3 2021$286,000
+157.7%
15,964
+22.6%
0.00%0.0%
Q1 2020$111,00013,0170.00%
Other shareholders
ATARA BIOTHERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Antipodean Advisors LLC 1,000,000$1,480,0007.58%
Redmile Group, LLC 6,280,813$9,295,6030.44%
Arctis Global LLC 397,046$587,6280.32%
Baupost Group 9,773,616$14,4650.28%
JOSH ARNOLD INVESTMENT CONSULTANT, LLC 230,000$413,4000.24%
MAVERICK CAPITAL LTD 6,290,713$9,310,2550.21%
683 Capital Management, LLC 1,200,000$1,776,0000.14%
STALEY CAPITAL ADVISERS INC 1,000,000$1,480,0000.08%
WASATCH ADVISORS LP 8,399,229$12,430,8590.08%
PACIFIC HEIGHTS ASSET MANAGEMENT LLC 525,000$777,0000.07%
View complete list of ATARA BIOTHERAPEUTICS INC shareholders